Ethicon endo’s voluntary recall of certain Proximate Circular staplers during the summer has turned in to an FDA Class I recall due to the serious consequences that can befall the patient in whom the stapler has not completely fired.
General Surgery
FDA Clears Novel Inguinal Hernia System Which Avoids Mesh Fixation
Insightra Medical has announced that its new Freedom inguinal hernia system has been cleared by the FDA. The device aims to address post-op chronic pain associated with traditional meshes by avoiding rigid fixation.
Given Imaging Taking The Pill
Capsule endoscopy company Given Imaging Ltd. has acquired from The SmartPill Corporation, a U.S. based-company, the assets related to the SmartPill® GI Monitoring System for $6 million including earn-outs based on revenue between now and 2016.
Will Japan Swallow Pillcam® Colon 2 Trial Data?
Given Imaging Ltd. developer of the Pillcam Colon 2 swallowable camera system for visualisation of the colorectal lining, has submitted compelling trial data to the Japanese authorities showing that 94% of polyps identified using standard colonoscopy were also spotted by its device.
Surgical Innovations Says There’s More Silver Lining Than Cloud In Its 6 Month Financials
Surgical Innovations has issued its 6 month financials which suggest the company has plenty of reasons to be cheerful as it looks forward to the fruits of new product approvals and distribution agreements in the U.S.
510(k) For iDrive™ Ultra Powered Stapling System Puts Smile Back On Covidien’s Face
Covidien says its newly FDA cleared device is the world’s only fully powered reusable surgical EndoStapling platform and claims it sets new standards in precision during surgery.
GI Endoscopy Market: Plenty More Fish In The Sea
Ageing population, improved screening and new treatments will drive GI Endoscopy market in U.S.A
500 Patient EndoBarrier® Pivotal Clinical Trial OK’d By FDA
GI Dynamics, Inc. has announced that it has received conditional approval from the U.S. FDA to commence what it’s calling a pivotal clinical trial of the EndoBarrier® for the treatment of patients who have uncontrolled type 2 diabetes and are obese.
540,000 Units Sold But It’s The End Of The Line For Covidien’s Duet TRS™ Reload
Covidien has announced that it is not only recalling all production lots for the Duet TRS™ Universal Straight and Articulating Single-Use Loading Units (SULU), but is in fact discontinuing the products.
CE Mark Means EndoStim LES Stimulator Is Now A treatment Option In Gastro-esophageal Reflux Disease
EndoStim B.V. has announced CE Mark approval of its LES Stimulation System for the treatment of gastro-esophageal reflux disease (GERD). The system uses low energy electrical pulses to strengthen a weak or dysfunctional lower esophageal sphincter muscle.
View From The Med: Can’t Quite Match The Olympics
Are the summer doldrums a good time to bury bad news or an opportunity to get your story to the top of the editor’s “hmmm interesting” list? We ponder this and other matters in our weekly View From The Med.
Is Ethicon Endo Hinting At User Issues As It Recalls Proximate PPH Pile Gun?
J&J subsidiary business Ethicon Endosurgery has issued a voluntary recall of certain lots of its PROXIMATE® PPH Hemorrhoidal Circular Stapler and Accessories. The recall was provoked by reports of difficulty firing the device although the company seems to have no problem doing so when reloading returned devices.
510(k) For Ethicon Endo’s New HARMONIC ACE®+ Shears With Adaptive Tissue Technology
Ethicon Endo-Surgery, Inc. has announced U.S. FDA 510(k) clearance of its HARMONIC ACE®+ Shears with Adaptive Tissue Technology. The company says this represents the next generation in its “best-in-class” HARMONIC® portfolio of ultrasonic surgical devices that can handle multiple surgical jobs.
Hill-Rom Completes Aspen Acquisition
Hill-Rom has completed its acquisition of Aspen Surgical Holdings in a move which the Batesville, Indiana outfit believes will enhance its presence in the surgical products market.
Now Xlumena’s Axios Stent CE Mark Approval Includes Biliary Tract Drainage
Xlumena, Inc. has announced that it has received CE Mark approval to market its AXIOS Stent and Delivery System for biliary tract drainage. The device was previously approved for the treatment of pancreatic pseudocysts.
Steris Hopes US Endoscopy Acquisition Will Expand Its Presence in GI Market
Steris Corporation is to acquire United States Endoscopy Group, Inc. and in so doing significantly expand its presence in the gastrointestinal(GI) procedural market with a franchise of proprietary, single-use consumable medical devices.